Free Trial
→ Ignore every stock… (From DTI) (Ad)

Sernova Q2 2023 Earnings Report

Sernova logo
$0.14 -0.01 (-8.84%)
As of 03:18 PM Eastern
Earnings HistoryForecast

Sernova EPS Results

Actual EPS
-$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Sernova Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Sernova Announcement Details

Quarter
Q2 2023
Date
6/13/2023
Time
N/A

Conference Call Resources

Sernova Earnings Headlines

Sernova Corp. Shareholders Approve Key Resolutions at Annual Meeting
January 14, 2025 | tipranks.com
Sernova Advances Diabetes Cure with Strategic Initiatives
January 14, 2025 | tipranks.com
Mode Mobile is poised for massive growth and looking to disrupt the $1T+ smartphone industry - Invest Today
While other cell phone carriers are always looking for ways to squeeze every last penny out of their customers, my company pays users for the 40 hours a week they are using smartphone apps, listening to music, and watching videos online with their phones. And you can join us for just $0.26 per share. Plus, when you invest now, you can get up to 100% bonus shares!
January 21, 2025 | Mode Mobile (Ad)
Sernova Announces Voting Results from its Annual and Special General Meeting of Shareholders
January 13, 2025 | finance.yahoo.com
Sernova Reschedules its Annual General and Special Meeting of Shareholders to January 10, 2025
December 20, 2024 | globenewswire.com
Sernova to Present at the 2024 Cell & Gene Meeting on the Mesa
October 3, 2024 | finance.yahoo.com
See More Sernova Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sernova? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sernova and other key companies, straight to your email.

About Sernova

Sernova (OTCMKTS:SEOVF) operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs. Sernova Corp. has a research agreement with the University of Miami to advance the development of Conformal Coating Technology in combination with therapeutic cells within Cell Pouch. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.

View Sernova Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles